FDA Warns About Johnson & Johnson COVID Vaccine and Guillain-Barré Syndrome Risk—Here's What That Means
2021-07-14
13
Of the 100 preliminary reports of Guillain-Barré syndrome, 95 were serious.
Please enable JavaScript to view the
comments powered by Disqus.
Videos similaires
More Than 500,000 At-Home COVID Tests Recalled, FDA Warns of Bacteria Risk
What to Know About At-Home COVID-19 Tests After FDA Warns Against Them
This TikTok User Says He Developed Guillain-Barré Syndrome After Having COVID-19—How Can That Happen?
FDA Warns Nitrate Poppers Cause 'Serious Adverse Health Effects
FDA Panel Approves Moderna COVID-19 Booster—Here's What That Means and What Happens Next
What Is an Endemic Virus? WHO Warns COVID-19 'May Never Go Away'
Dr. Fauci Warns That These 3 Businesses Should Close in Many Places to Prevent a COVID-19
WHO Warns Against Mixing COVID Vaccines—Here's What We Know So Far
CDC Director Warns of ‘Impending Doom’ as COVID-19 Cases Increase Across the US
FDA Approves the Pfizer Vaccine, Now Called Comirnaty—Here's What FDA Approval Means
